Behbahani Ali (CIK 1613867) reported 45 SEC Form 4 insider transactions across 9 companies over the past 18 months (most recent 2026-09-21). Recent activity: Buy BDTX (7,707 shares), Buy CRSP (60 shares), Buy CRSP (30,000 shares), Buy CRSP (15 shares), Sell CRSP (13,679 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-21 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 7,707 | $14,875 |
| 2026-09-21 | CRISPR Therapeutics AG (CRSP) | Director | Buy | 60 | $0 |
| 2026-09-21 | CRISPR Therapeutics AG (CRSP) | Director | Buy | 30,000 | $420,000 |
| 2026-09-21 | CRISPR Therapeutics AG (CRSP) | Director | Buy | 15 | $0 |
| 2026-09-21 | CRISPR Therapeutics AG (CRSP) | Director | Sell | 13,679 | $780,935 |
| 2026-07-06 | Monte Rosa Therapeutics, Inc. (GLUE) | Director | Sell | 1.0M | $0 |
| 2026-07-06 | Monte Rosa Therapeutics, Inc. (GLUE) | Director | Buy | 15,000 | $0 |
| 2026-07-06 | Monte Rosa Therapeutics, Inc. (GLUE) | Director | Sell | 15,000 | $0 |
| 2026-06-22 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 8,961 | $14,875 |
| 2026-04-28 | Arcellx, Inc. (ACLX) | Director | Sell | 1,925 | $0 |
| 2026-04-28 | Arcellx, Inc. (ACLX) | Director | Sell | 2,706 | $0 |
| 2026-03-20 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 6,919 | $14,876 |
| 2026-03-12 | Korro Bio, Inc. (KRRO) | Director | Buy | 207,100 | $2.3M |
| 2026-02-13 | Trevi Therapeutics, Inc. (TRVI) | 10% Owner | Buy | 1.9M | $2.5M |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 1.6M | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 1.4M | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 1.4M | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 737,962 | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 937,500 | $15.0M |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 954,990 | $0 |
| 2026-02-11 | SpyGlass Pharma, Inc. (SGP) | Director | Buy | 402,273 | $0 |
| 2025-12-15 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 5,208 | $14,374 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 189,195 | $1,892 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Sell | 280 | $1,890 |
| 2025-10-06 | NeueHealth, Inc. (NEUE) | Director | Buy | 372,255 | $3,723 |
来源：SEC Form 4 申报文件 · 截至 2026-09-21